Macquarie Group Ltd. Boosts Holdings in Waters Co. (WAT)

Share on StockTwits

Macquarie Group Ltd. boosted its position in shares of Waters Co. (NYSE:WAT) by 52.9% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 2,600 shares of the medical instruments supplier’s stock after buying an additional 900 shares during the period. Macquarie Group Ltd.’s holdings in Waters were worth $490,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. Athena Capital Advisors LLC purchased a new stake in Waters during the 4th quarter worth approximately $28,000. Rockland Trust Co. purchased a new stake in Waters during the 4th quarter worth approximately $38,000. Reilly Financial Advisors LLC increased its stake in Waters by 334.8% during the 4th quarter. Reilly Financial Advisors LLC now owns 200 shares of the medical instruments supplier’s stock worth $38,000 after buying an additional 154 shares in the last quarter. Lindbrook Capital LLC purchased a new stake in Waters during the 4th quarter worth approximately $41,000. Finally, Financial Gravity Companies Inc. purchased a new stake in Waters during the 4th quarter worth approximately $64,000. Institutional investors own 94.86% of the company’s stock.

In other news, Director Thomas P. Salice sold 2,000 shares of the company’s stock in a transaction that occurred on Wednesday, January 30th. The stock was sold at an average price of $231.59, for a total value of $463,180.00. Following the completion of the sale, the director now directly owns 20,010 shares in the company, valued at $4,634,115.90. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Terrence P. Kelly sold 2,006 shares of the company’s stock in a transaction that occurred on Monday, March 11th. The shares were sold at an average price of $239.69, for a total value of $480,818.14. The disclosure for this sale can be found here. Insiders sold 105,032 shares of company stock valued at $24,284,760 over the last 90 days. Company insiders own 0.98% of the company’s stock.

Several equities research analysts have commented on the company. Zacks Investment Research lowered Waters from a “strong-buy” rating to a “hold” rating in a research note on Friday. Barclays reiterated a “hold” rating and set a $200.00 price objective on shares of Waters in a research note on Friday, January 25th. BTIG Research boosted their price objective on Waters to $260.00 and gave the stock a “buy” rating in a research note on Thursday, January 24th. Robert W. Baird lowered Waters from an “outperform” rating to a “neutral” rating and boosted their price objective for the stock from $191.00 to $211.00 in a research note on Thursday, January 24th. Finally, TheStreet upgraded Waters from a “c+” rating to a “b” rating in a research note on Thursday, January 17th. Two analysts have rated the stock with a sell rating, twelve have issued a hold rating and two have given a buy rating to the company’s stock. Waters has a consensus rating of “Hold” and an average target price of $208.99.

WAT stock opened at $250.88 on Monday. The company has a quick ratio of 5.28, a current ratio of 5.93 and a debt-to-equity ratio of 0.73. The company has a market capitalization of $17.74 billion, a PE ratio of 30.26, a P/E/G ratio of 2.48 and a beta of 1.19. Waters Co. has a 1 year low of $167.93 and a 1 year high of $255.21.

Waters (NYSE:WAT) last posted its quarterly earnings results on Wednesday, January 23rd. The medical instruments supplier reported $2.87 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.64 by $0.23. The business had revenue of $715.00 million during the quarter, compared to analyst estimates of $702.74 million. Waters had a return on equity of 34.18% and a net margin of 24.54%. The business’s revenue was up 4.0% compared to the same quarter last year. During the same period in the prior year, the business earned $2.51 earnings per share. Equities research analysts predict that Waters Co. will post 9.35 EPS for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “Macquarie Group Ltd. Boosts Holdings in Waters Co. (WAT)” was first reported by Week Herald and is the property of of Week Herald. If you are accessing this piece of content on another website, it was stolen and reposted in violation of U.S. & international copyright law. The original version of this piece of content can be viewed at https://weekherald.com/2019/04/15/macquarie-group-ltd-boosts-holdings-in-waters-co-wat.html.

Waters Company Profile

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in the United States, Europe, Asia, and internationally. It designs, manufactures, sells, and services high and ultra performance liquid chromatography technology, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

See Also: Short Selling Stocks and Day Traders

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WAT).

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.